Clinical trial
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403…
NCT00101621 · MetaPhore Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00101621 |
|---|---|
| Title | Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain |
| Official title | A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent in a Cancer Pain Model |
| Lead sponsor | MetaPhore Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Pain |
| Intervention type | Drug |
| Interventions | M40403 |
| Enrollment | 24 |
| Start date | Aug 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Jan 13, 2005 |
| Last update posted | Feb 9, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: